Today: 21 May 2026
Chevron stock jumps on Trump Venezuela oil move; traders eye sanctions and Jan. 30 earnings

Chevron stock jumps on Trump Venezuela oil move; traders eye sanctions and Jan. 30 earnings

New York, Jan 5, 2026, 13:39 EST — Regular session

  • Chevron shares rose about 6% as investors priced in possible access to Venezuela’s oil reserves after the Maduro capture.
  • Chevron’s existing Venezuela footprint and demand for heavy crude on the U.S. Gulf Coast sharpened the focus on refiners and upstream names.
  • The next scheduled catalyst is Chevron’s Jan. 30 earnings call, where investors want clarity on cash returns and Venezuela exposure.

Chevron (CVX) shares rose 5.7% to $164.78 in early afternoon trading on Monday, after swinging between $159.33 and $171.50. ConocoPhillips (COP) gained 3.3% and Exxon Mobil (XOM) added 2.4% as traders rotated into oil names after U.S. forces captured Venezuelan President Nicolás Maduro and investors bet the move could reshape access to the country’s crude.

The rally matters now because Chevron is the only U.S. major still operating in Venezuela under a U.S. waiver — government permission to keep working despite sanctions — leaving it positioned to move faster if policy shifts. Venezuelan barrels are typically “heavy sour” crude, meaning thick oil with higher sulfur that many U.S. Gulf Coast plants are built to process. “This type of crude aligns well with the configuration of U.S. Gulf Coast refineries,” said Ahmad Assiri, a research strategist at Pepperstone. Reuters

Chevron stayed in the country through joint ventures with state oil company PDVSA and holds stakes of between 25% and 60% in five onshore and offshore projects, a Reuters factbox showed. Ship-tracking data cited by Reuters showed Chevron exported about 150,000 barrels per day (bpd) of Venezuelan crude to the U.S. Gulf Coast in November and about 100,000 bpd in December. Foreign firms need U.S. authorizations to plan and operate projects, and Venezuela’s oil exports are currently at a standstill under Washington’s sanctions, the factbox said.

Behind the bid was a second wager: a policy reset could also reopen a path for compensation tied to assets seized in Venezuela’s nationalizations. White House and State Department officials have told U.S. oil executives in recent weeks that companies would need to return quickly and commit significant capital to revive the industry if they wanted compensation, Reuters reported; Conoco has sought to recover about $12 billion and Exxon has pursued about $1.65 billion through international arbitration, a legal process that can award compensation in cross-border disputes.

Oil prices firmed as markets tried to map how Venezuelan flows might change amid the upheaval. Brent crude futures were up 1.58% at $61.71 a barrel by 12:56 p.m. EDT, while U.S. West Texas Intermediate (WTI) — the main U.S. crude benchmark — gained 1.66% to $58.27, Reuters reported.

But analysts caution that turning headlines into higher Venezuelan output will take time: they see a rise of up to 500,000 bpd over the next two years only if the country stabilizes and U.S. companies invest. A bigger ramp would require years, major capital and a workable legal framework, with security and infrastructure concerns still in play. Goldman Sachs said a scenario in which Venezuela climbs to 2 million bpd could shave about $4 a barrel off oil prices by 2030, even as it kept its 2026 average forecasts at $56 for Brent and $52 for WTI.

For Chevron, the near-term question is less about immediate barrels and more about what Washington does with licenses and sanctions — and whether any roadmap emerges for financing, security and contractual terms. Until then, crude prices and downstream margins remain the day-to-day drivers that tend to set the tone for big integrated oil stocks.

Chevron said it will hold its quarterly earnings conference call on Friday, Jan. 30 at 11:00 a.m. ET, with Chief Executive Mike Wirth and Chief Financial Officer Eimear Bonner scheduled to speak. Investors are likely to press the company on how it is managing its Venezuela exposure under existing authorizations and what it would need to expand activity if restrictions change.

The next hard date for CVX is that Jan. 30 call — and traders will be listening for any change in how management frames Venezuela risk, potential investment requirements and the pace of any policy-led reopening.

Stock Market Today

  • SpaceX Set to Go Public: Key Details and Market Impact
    May 20, 2026, 8:02 PM EDT. SpaceX, founded by Elon Musk, is poised to go public, joining hundreds of companies that raised $70 billion in U.S. equity markets last year. Going public means the company will offer shares for sale on stock exchanges, allowing investors to buy ownership stakes. This move could unlock significant capital for SpaceX's ambitious space ventures, while providing early investors a chance to realize gains. The offering is closely watched amid a strong appetite for tech and aerospace stocks, reflecting broader market interest in innovation-driven firms.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Nike stock climbs as BTIG tags $100 target, UBS sees stronger brand signals
Previous Story

Nike stock climbs as BTIG tags $100 target, UBS sees stronger brand signals

HDFC Bank share price drops after Q3 update shows loans outpacing deposits — what investors watch next
Next Story

HDFC Bank share price drops after Q3 update shows loans outpacing deposits — what investors watch next

Go toTop